| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063614 Transformed fungal strains free of selection marker |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063607 Polypeptides having choline oxidase activity and nucleic acids encoding same |
| 05/16/2000 | US6063601 Chimaeric gene coding for a transit peptide and a heterologous peptide |
| 05/16/2000 | US6063598 Strong homologous promoter obtained from hamsters |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063375 Semiallogeneic cell hybrids and related methods for treating cancer |
| 05/16/2000 | US6063373 Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026417A1 Detection of negative-strand rna viruses |
| 05/11/2000 | WO2000026408A2 A system for cell-based screening |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026401A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026391A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 05/11/2000 | WO2000026390A2 Genes and vectors for conferring herbicide resistance in plants |
| 05/11/2000 | WO2000026388A2 Novel expression cassette for expressing genes in plant seed |
| 05/11/2000 | WO2000026383A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | WO2000026381A2 High fidelity thermostable ligase and uses thereof |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026371A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026369A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | WO2000026363A1 GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026357A2 Transgenic and cloned mammals |
| 05/11/2000 | WO2000026355A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 05/11/2000 | WO2000026354A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026347A1 Methods for the production of tcr gamma delta t cells |
| 05/11/2000 | WO2000026345A1 Glufosinate tolerant rice |
| 05/11/2000 | WO2000026344A1 Peptides with enhanced stability to protease degradation |
| 05/11/2000 | WO2000026343A2 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals |
| 05/11/2000 | WO2000026338A1 Method for culturing microorganisms in prefilled flexible containers |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
| 05/11/2000 | WO2000026230A1 Low allergenic protein variants |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | WO2000025813A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 05/11/2000 | WO2000025812A2 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/11/2000 | WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000008164A3 Thermostable in vitro complex with polymerase activity |
| 05/11/2000 | WO2000008130A3 Method for preparing a cartilage cell suspension |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/11/2000 | WO2000006087A3 Uncoupling protein-2(hcp2): compositions and methods of use |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | WO1999053036A3 Ste20-related protein kinases |
| 05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
| 05/11/2000 | DE19852906A1 Vitamin E bindende Antikörper, Minianitkörper oder Antikörperfragmente und ihre Verwendung Vitamin E binding antibodies, or antibody fragments Minianitkörper and their use |
| 05/11/2000 | CA2795377A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2525148A1 Transgenic and cloned mammals |
| 05/11/2000 | CA2350233A1 Transgenic and cloned mammals |
| 05/11/2000 | CA2350085A1 Methylated cpg island amplification (mca) |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349759A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349473A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2349428A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | CA2349212A1 Myosin heavy chain homolog |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | CA2348962A1 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348957A1 Detection of negative-strand rna viruses |
| 05/11/2000 | CA2348938A1 Low allergenic protein variants |
| 05/11/2000 | CA2348888A1 Novel expression cassette for expressing genes in plant seed |
| 05/11/2000 | CA2348822A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | CA2348777A1 Rotavirus subunit vaccine |
| 05/11/2000 | CA2348756A1 Enhanced vaccines |
| 05/11/2000 | CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 05/11/2000 | CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators |